- pause slideshow
Rare but not forgotten: why drug appraisal methods must be updated to consider treatments for rare diseasesSubscription
The UK government needs to adapt its drug and technology appraisal methods to prevent patients with rare diseases being left out in the cold.
As pharmacy contractors in England suffer budget cuts and their leaders instigate legal action, Northern Ireland pharmacy contractor Terry Maguire argues why this might not be a good idea and what English contractors might learn from their Celtic cousins.
Evidence is emerging that biocides and heavy metals all contribute to the growing problem of antimicrobial resistance.
Previous court cases concerning informed consent of treatment have raised questions about what consent means in relation to pharmacists, medicines and prescribing.
While the implications of Brexit on drug regulation in the UK are largely unknown, the government needs to consider its options quickly to avoid delaying public access to important medicine.
The new urgent medicine supply scheme from NHS England requires more thought and revision.
Your RPS needs youSubscription
Show your passion and dedication to pharmacy by putting yourself forward for this year’s RPS national pharmacy board elections.
Recommendations made in Murray’s review for community pharmacy will not be simple to implementSubscription
Practical challenges, including building closer relationships with GPs, will need to be overcome if the recommendations in the Murray review on community pharmacy are to be implemented successfully.
Limiting HIV resistance must not be neglected in an era where we continue to see breakthroughs in treatment for the infection once labelled a death sentence.
Cholesterol-lowering statin therapy for healthy people is not as simple as 'yes' or 'no'Subscription
Recent reports of large trials extolling the virtues of statins have led many to believe that low-risk patients should take them, but an examination of the evidence provides food for thought.
There are a number of factors that contribute to patients’ fear and reluctance to take osteoporosis drugs, leaving them at increased risk of fractures.
Research suggests no substantive outcome differences between the use of originator biologics and their biosimilar counterparts Source: Shutterstock.com
Restricting what is allowed on prescription in England: views from healthcare professionals and patient groupsSubscription
We ask healthcare professionals across primary care and patient groups for their thoughts on NHS England’s decision to review what GPs are allowed to prescribe.
Q&A: How to ensure access to essential medicines for those in low and middle-income countriesSubscription
Andy Gray and Hans Hogerzeil, co-chairs of the The Lancet Commission on Essential Medicines, discuss the analysis on the cost of providing essential medicines to people in low and middle-income countries.
Shanelle Hall from UNICEF discusses the breakthrough pentavalent vaccine three-year tender with six vaccine suppliers.
The author of the 2013 report which looked at patient safety in the NHS after the Mid Staffordshire Hospital scandal speaks to Jenny Bryan to share his thoughts on whether progress has been made.
How telomeres affect your health and longevitySubscription
The telomere effect by Elizabeth Blackburn and Elissa Epel
Tender is the scalpel’s edge, by Gautam Das.
A fascinating look at the history of toxicologySubscription
Toxicology in the middle ages and renaissance, edited by Philip Wexler
Comprehensive drug reference resource from the American Society of Health-System PharmacistsSubscription
This new edition of the popular drug reference includes oncology drugs approved under the US Food and Drug Administration’s accelerated approval programme.
It’s RPS national board election time againSubscription
Alex MacKinnon, interim chief executive of the Royal Pharmaceutical Society, makes a plea for members to use their vote in the 2017 national board elections.
The Royal Pharmaceutical Society (RPS) Welsh Pharmacy Board launched its manifesto in November 2015. Mair Davies, director for RPS Wales, talks to Julia Robinson about progress made since the launch, and her objectives for 2017 and beyond.
New RPS director for England, Robbie Turner, tells Julia Robinson about his plans for 2017 and how he hopes his experience as chief executive of Community Pharmacy West Yorkshire will help him achieve his goals.
Alex MacKinnon, director for the Scotland at the Royal Pharmaceutical Society (RPS), tells Julia Robinson what 2017 will mean for pharmacists in Scotland and how RPS Scotland plans to embrace new opportunities on behalf of the profession.
Homelessness is a continuing social concern across the UK. In Glasgow there are an estimated 500 people sleeping rough on the streets at any one time. In England the number of people sleeping rough has risen consecutively for the past 6 years
RPS board members must champion our aspirationsSubscription
The Royal Pharmaceutical Society (RPS) may struggle to engage its membership, particularly those early in their careers. To find solutions, it is natural to look to the elder statesmen of the profession. However, the next generation of pharmacists are watching this RPS election with a keen eye. Although I have no vote, I hope to see board members elected who will take account of our aspirations and expectations. Undoubtedly, the profession and the Society face mounting challenges and ...
Two-thirds of people with asthma in the UK say poor air quality makes their asthma worse, which puts them at higher risk of an asthma attack.
Hello my name is Hala Jawad. I have a special interest in public health and improving patient outcomes. I am delighted to be standing for the Royal Pharmaceutical Society (RPS) English Pharmacy Board elections in 2017.
Briony Hudson provides highlights from this year’s British Society for the History of Pharmacy conference, and examines the lack of engagement from pharmacist in pharmacy history.
Shane Kailla describes his experience of pharmacy practice in Shanghai, China, during his 2016 summer placement.
We are calling for article submissions that highlight best practice in relation to the management of long-term conditions.
The reported shortage of a popular throat mixture has sent panic across the entertainment industry because of its popularity with actors, singers and performers.
Thomas Geoffrey Booth (1928-2016)Subscription
Thomas Geoffrey Booth, past president of the Royal Pharmaceutical Society, founded the UK’s first department of pharmacy practice.
Frank P Palopoli (1922–2016) Subscription
The scientist who discovered the fertility drug clomifene was known as a modest man who mentored his staff.
Kirit Patel (1949-2016)Subscription
A self-made man who started out wanting to own a shop to support his family, Kirit Patel’s lifetime achievements are inspirational.
Philip Majerus (1936-2016)Subscription
Majerus was one of the first researchers who discovered the benefits of low dose aspirin in preventing heart attacks and strokes.